Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Long Term Outcomes with Pembrolizumab
Post ASCO 2019 Lung Cancer Round Table Discussion - Long Term Outcomes with Pembrolizumab
Author
Howard (Jack) West, MD
Image

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, and Founder, President and CEO Of GRACE, Charu Aggarwal, MD, MPH with the Perelman Center for Advanced Medicine, University of Pennsylvania, and Benjamin Levy MD, Clinical Director Of Medical Oncology, Assistant Professor Of Oncology at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.

The doctors recently collaborated from their respective geographical locations to review top discussion points from Lung Cancer from ASCO 2019.  In this video, the doctors discuss long term outcomes with Pembrolizumab.

 

Please visit our community forums with any questions or comments! 

 
Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
videoteca de cáncer de pulmón
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2023, el Dr.
Image
Cased Based Panel Discussions - Lung Cancer
Video
In these videos, the panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and looks at data from the Laura Trial. They also discuss treatment options for a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions.